Amlodipine And Atorvastatin Tablet, Film Coated
Product Images NDC 71335-2924

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Amlodipine And Atorvastatin (NDC 71335-2924). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Amlodipine Besylate And Atorvastatin Calcium 02)

Figure 1 (Amlodipine Besylate And Atorvastatin Calcium 02)
This text provides information on the event rate in a study, including a P-value of 0.003, a Hazard Ratio of 0.691, and a 95% Confidence Interval of (0.54, 0.88). It seems to involve a comparison between two groups, one possibly related to the medication "Amlodipine". The timeline is indicated in months, making it a clinical or research study.*
FDA Label Image

Figure 2 (Amlodipine Besylate And Atorvastatin Calcium 03)

FDA Label Image

Figure 3 (Amlodipine Besylate And Atorvastatin Calcium 04)

FDA Label Image

Figure 4 (Amlodipine Besylate And Atorvastatin Calcium 05)

Figure 4 (Amlodipine Besylate And Atorvastatin Calcium 05)
This text provides information on the cumulative hazard (%) for Placebo and Atorvastatin as well as the Hazard Ratio (HR) and corresponding p-value. It also mentions the time to the first primary endpoint over a four-year follow-up period.*
FDA Label Image

Figure 5 (Amlodipine Besylate And Atorvastatin Calcium 06)

Figure 5 (Amlodipine Besylate And Atorvastatin Calcium 06)
This text provides data on the percentage of subjects experiencing an event, specifically related to the use of Atorvastatin at two different doses (10 mg and 80 mg). It also includes hazard ratio (HR) with confidence interval and p-value for the comparison. The information is related to the time taken to reach the first major cardiovascular endpoint in years.*
FDA Label Image

Amlodipine (Amlodipine)

FDA Label Image

Atorvastatin-glycol-solvate (Atorvastatin Glycol Solvate)

FDA Label Image

Label (Lbl713352924)

Label (Lbl713352924)
The text appears to be a description of a medication containing a combination of Amlodipine Besylate and Atorvastatin Calcium. Each film-coated tablet is equivalent to 10 mg Amlodipine and 10 mg Atorvastatin. The medication should be kept out of the reach of children and protected from moisture. It should be stored at temperatures between 20°C to 25°C. The text also mentions the manufacturer and indicates the usual dosage.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.